A detailed history of Two Sigma Securities, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Two Sigma Securities, LLC holds 12,782 shares of NVO stock, worth $1.08 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
12,782
Previous 108,626 88.23%
Holding current value
$1.08 Million
Previous $15.5 Million 90.19%
% of portfolio
0.03%
Previous 0.19%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $11.4 Million - $13.9 Million
-95,844 Reduced 88.23%
12,782 $1.52 Million
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $2.28 Million - $2.73 Million
18,581 Added 20.64%
108,626 $15.5 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $8.34 Million - $11.1 Million
81,688 Added 977.48%
90,045 $11.6 Million
Q4 2023

Feb 14, 2024

SELL
$87.78 - $105.45 $4.49 Million - $5.4 Million
-51,178 Reduced 85.96%
8,357 $864,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $4.49 Million - $9.86 Million
49,392 Added 486.96%
59,535 $5.41 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $311,024 - $344,264
1,994 Added 24.47%
10,143 $1.64 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $1.08 Million - $1.3 Million
8,149 New
8,149 $1.3 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $204,756 - $251,282
2,149 New
2,149 $214,000
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $229,119 - $276,960
2,461 New
2,461 $273,000
Q3 2020

Nov 16, 2020

SELL
$63.69 - $70.22 $426,977 - $470,754
-6,704 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $392,452 - $455,469
6,704 New
6,704 $439,000
Q1 2020

May 15, 2020

SELL
$49.46 - $64.78 $192,349 - $251,929
-3,889 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $253,488 - $296,193
-5,084 Reduced 56.66%
3,889 $225,000
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $130,687 - $146,879
2,749 Added 44.17%
8,973 $464,000
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $291,220 - $326,573
6,224 New
6,224 $318,000
Q4 2018

Feb 14, 2019

SELL
$41.54 - $47.25 $293,438 - $333,774
-7,064 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $9,352 - $10,248
200 Added 2.91%
7,064 $333,000
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $304,006 - $346,082
6,864 New
6,864 $317,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $191B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.